{"id":23184,"date":"2018-08-12T22:45:54","date_gmt":"2018-08-13T02:45:54","guid":{"rendered":"http:\/\/beyondpesticides.org\/dailynewsblog\/?p=23184"},"modified":"2020-01-07T18:40:30","modified_gmt":"2020-01-07T22:40:30","slug":"groundskeeper-used-monsantos-herbicide-roundup-contracted-cancer-non-hodgkin-lymphoma-nhl-wins-289-million-jury-verdict","status":"publish","type":"post","link":"https:\/\/beyondpesticides.org\/dailynewsblog\/2018\/08\/groundskeeper-used-monsantos-herbicide-roundup-contracted-cancer-non-hodgkin-lymphoma-nhl-wins-289-million-jury-verdict\/","title":{"rendered":"Groundskeeper Who Used Monsanto\u2019s Herbicide Roundup and Contracted the Cancer non-Hodgkin lymphoma (NHL) Wins $289 Million Jury Verdict"},"content":{"rendered":"
<\/div>\n

\"\"<\/p>\n

(Beyond Pesticides<\/em>, August 12, 2018) In a stunning legal victory for a man who contracted non-Hodgkin lymphoma (NHL) after using the herbicide glyphosate (Roundup)<\/a>, groundskeeper Dewayne Johnson won a $289 million jury verdict against the chemical’s manufacturer, Monsanto. The jury on August 10, 2018 awarded the 46-year old Mr. Johnson $39 million in compensatory damages, and $250 million in punitive damages. The jury found that Monsanto acted with \u201cmalice or oppression.\u201d<\/p>\n

“We applaud and thank Mr. Johnson, and his family and attorneys, for persevering in this litigation, which sets a critically important standard for protecting people’s right not be poisoned by pesticides in the marketplace,” said Jay Feldman, executive director of Beyond Pesticides. Mr. Feldman continued: “While we know that the jury verdict cannot restore Mr. Johnson’s health, we believe that the verdict is a clarion call to manufacturers that ignore the devastating impact that their products can have on unsuspecting workers, consumers, and families. We look forward to the day in the not-too-distant future when we recognize as a society that products like glyphosate (Roundup) are not necessary, and effective and affordable land and building management can be achieved without toxic chemicals. The case should also signal to all levels of government \u2013 local, state, and federal \u2013 that we have a social, public health, and environmental responsibility to remove toxic pesticides from use with a high degree of urgency.”<\/p>\n

The law firms representing Mr. Johnson, the Miller Firm<\/a>\u00a0and\u00a0Baum, Hedlund, Aristei & Goldman<\/a>, describes the case (reprinted below) as follows:<\/strong><\/p>\n

Dewayne Johnson v. Monsanto Company<\/em>\u00a0is\u00a0the first Roundup cancer lawsuit to proceed to trial<\/a>. The lawsuit alleges exposure to Monsanto\u2019s Roundup weed killer and its active ingredient, glyphosate, caused Northern California resident Dewayne \u201cLee\u201d Johnson to develop non-Hodgkin lymphoma (NHL).<\/p>\n

Quick link to trial transcripts<\/strong><\/a><\/p>\n

Quick link to trial exhibits<\/a><\/strong><\/p>\n

Quick link to trial news<\/strong><\/a><\/p>\n

Lee Johnson worked as a groundskeeper for the\u00a0Benicia Unified School District<\/a>\u00a0in the San Francisco Bay Area. Between 2012 and 2015, part of Mr. Johnson\u2019s job was to apply Monsanto herbicides to school properties.<\/p>\n

In 2014, Lee began to experience severe skin irritation, which he reported to health care providers. He also contacted Monsanto, asking if his skin irritation could have been caused by his use of Roundup. Internal Monsanto emails later obtained by Lee\u2019s attorneys show that his queries concerning Roundup were discussed among company employees. However, Monsanto never responded to Mr. Johnson, so he continued to use Roundup.<\/p>\n

In August of 2014, Lee was diagnosed with epidermotropic T-cell lymphoma. After his diagnosis, his job still required him to apply and be in close contact with Monsanto glyphosate-based herbicides. Despite enduring chemotherapy treatments throughout 2015, Mr. Johnson\u2019s cancer progressed. In September 2017, a biopsy\u00a0revealed mycosis fungoides (non-Hodgkin lymphoma with large cell transformation)<\/a>.<\/p>\n

Mr. Johnson filed a Roundup cancer lawsuit against Monsanto in 2016. He is represented by\u00a0the Miller Firm<\/a>\u00a0and\u00a0Baum, Hedlund, Aristei & Goldman<\/a>.<\/p>\n

In the documents below, you will find trial transcripts and exhibits (posted after 48-hour delay) and other court documents from\u00a0Dewayne Johnson v. Monsanto Company.<\/em>\u00a0For access to all public documents in this case, you can\u00a0view the docket<\/a>\u00a0via the Superior Court of California, County of San Francisco.<\/p>\n

If you are looking for the court documents from the federal Monsanto Roundup litigation (MDL),\u00a0<\/em><\/strong>please visit the Monsanto Court Papers page<\/em><\/strong><\/a>.<\/p>\n

If you are looking for unsealed Monsanto emails, communications, studies and other memoranda,\u00a0<\/em><\/strong>please\u00a0visit the Monsanto Papers page<\/em><\/strong><\/a>.<\/em><\/strong><\/p>\n

Dewayne Johnson v. Monsanto Trial Transcripts<\/strong><\/p>\n

Day 1: 7\/9\/18<\/a>\u00a0\u2013 Plaintiff opening statement by R. Brent Wisner and Defense opening statement by George C. Lombardi<\/p>\n

Day 2: 7\/10\/18<\/a>\u00a0\u2013 Video deposition of Dr. Mark Martens, former Monsanto executive, Toxicology Agriculture Research & Development Director for Monsanto Europe and video deposition of Dr. William Heydens, Product Safety Assessment Strategy Lead<\/p>\n

Day 3 A: 7\/12\/18<\/a>\u00a0\u2013 Dr. Christopher Portier, former Director of the Agency for Toxic Substances and Disease Registry, direct by Brent Wisner<\/p>\n

Day 3 B: 7\/12\/18<\/a>\u00a0\u2013 Dr. Christopher Portier direct by Brent Wisner resumed<\/p>\n

Day 4 A: 7\/13\/18<\/a>\u00a0\u2013 Dr. Christopher Portier direct by Brent Wisner resumed, cross by Kirby Griffis<\/p>\n

Day 4 B: 7\/13\/18<\/a>\u00a0\u2013 Dr. Christopher Portier cross by Kirby Griffis resumed<\/p>\n

Day 5 A: 7\/16\/18<\/a>\u00a0\u2013 Dr. Christopher Portier cross by Kirby Griffis resumed<\/p>\n

Day 5 B: 7\/16\/18<\/a>\u00a0\u2013 Dr. Christopher Portier cross by Kirby Griffis resumed, redirect by Brent Wisner<\/p>\n

Day 6 A: 7\/17\/18<\/a>\u00a0\u00a0\u2013 Dr. Christopher Portier redirect by Brent Wisner resumed, video deposition of Dr. William Heydens continued from Day 2, Monsanto Co. Product Safety Assessment Strategy Lead<\/p>\n

Day 6 B: 7\/17\/18<\/a>\u00a0\u2013 \u00a0 Video deposition of Daniel Jenkins, Monsanto\u2019s former US Agency Manager for Regulatory Affairs, video deposition of Daniel Goldstein, Monsanto Co. Lead, Medical Sciences and Outreach and Distinguished Science Fellow<\/p>\n

Day 7 A: 7\/18\/18<\/a>\u00a0\u2013 Dr. Alfred Neugut, medical oncologist and cancer epidemiologist at Columbia University, direct by Brent Wisner<\/p>\n

Day 7 B: 7\/18\/18<\/a>\u00a0\u2013 Dr. Alfred Neugut\u00a0direct by Brent Wisner resumed, cross by George Lombardi, redirect by Brent Wisner, recross by George Lombardi, re-redirect by Brent Wisner<\/p>\n

Day 8 A: 7\/20\/18<\/a>\u00a0\u2013 Dr. Chadi Nabhan, hematologist and medical oncologist, direct by David Dickens<\/p>\n

Day 8 B: \u00a07\/20\/18<\/a>\u00a0\u2013 Dr. Chadi Nabhan, direct by David Dickens resumed, cross by George Lombardi, redirect by David Dickens, recross by George Lombardi, re-redirect by David Dickens<\/p>\n

Day 9 A: 7\/23\/18<\/a>\u00a0\u2013 Dr. Ope Ofodile, Mr. Johnson\u2019s dermatologist, direct by Brent Wisner, redirect by Kirby Griffis; Araceli Johnson, plaintiff\u2019s wife, direct by David Dickens; Dewayne \u201cLee\u201d Johnson, plaintiff, direct by David Dickens<\/p>\n

Day 9 B: 7\/23\/18<\/a>\u00a0\u2013 Dewayne \u201cLee\u201d Johnson, plaintiff, direct by David Dickens resumed, cross by Sandra Edwards, video deposition of Daniel Goldstein resumed<\/p>\n

Day 10 A: 7\/24\/18<\/a>\u00a0\u2013 Video deposition of Daniel Goldstein resumed, video deposition of Donna Farmer, Product Protection and Nutrition Lead, Monsanto Company<\/p>\n

Day 10 B: 7\/24\/18<\/a>\u00a0\u2013 Video deposition of Donna Farmer resumed<\/p>\n

Day 11: 7\/25\/18 \u2013 No transcripts \u2013 Jury not present \u2013 though exhibits were admitted<\/p>\n

Day 12 A: 7\/26\/18<\/a>\u00a0\u2013 William Robert Sawyer, toxicologist, direct by David Dickens<\/p>\n

Day 12 B: 7\/26\/18<\/a>\u00a0\u2013 William Robert Sawyer, direct by David Dickens resumed, cross by George Lombardi, redirect by David Dickens, recross by George Lombardi<\/p>\n

Day 13 A: 7\/27\/18<\/a>\u00a0\u2013 Charles Benbrook, scientist and agricultural economist, direct by Brent Wisner<\/p>\n

Day 13 B: 7\/27\/18<\/a>\u00a0\u2013 Charles Benbrook direct by Brent Wisner resumed, cross by Kirby Griffis, redirect by Brent Wisner, recross by Kirby Griffis<\/p>\n

Day 14 A: 7\/30\/18<\/a>\u00a0\u2013 Dr. Kassim Al-Khatib, professor and weed scientist, direct by Sandra Edwards,\u00a0voir dire<\/em>\u00a0examination by Brent Wisner, cross by Brent Wisner<\/p>\n

Day 14 B: 7\/30\/18<\/a>\u00a0\u2013 Cross resumed by Brent Wisner, redirect by Sandra Edwards, recross by Brent Wisner, video deposition of Dr. Matthew Ross played, video deposition of epidemiologist Aaron Blair played.<\/p>\n

Day 15 A: 7\/31\/18<\/a>\u00a0\u2013 Lorelei Mucci, associate professor of epidemiology, direct by George Lombardi,\u00a0voir dire<\/em>\u00a0examination by Brent Wisner, direct resumed by George Lombardi<\/p>\n

Day 15 B: 7\/31\/18<\/a>\u00a0\u2013 Lorelei Mucci, cross by Brent Wisner, redirect by George Lombardi, recross by Brent Wisner<\/p>\n

Day 16 A: 8\/2\/18<\/a>\u00a0\u2013 Dr. Warren Foster, direct by Kirby Griffis,\u00a0voir dire<\/em>\u00a0examination by Brent Wisner, direct resumed by Kirby Griffis<\/p>\n

Day 16 B: 8\/2\/18<\/a>\u00a0\u2013 Dr. Warren Foster, direct continued by Kirby Griffis, cross by Brent Wisner, redirect by Kirby Griffis, recross by Brent Wisner<\/p>\n

Day 17 A: 8\/3\/18<\/a>\u00a0\u2013 Dr. Timothy Kuzel, hematologist and oncologist, direct by Kirby Griffis,\u00a0voir dire<\/em>\u00a0examination by David Dickens, direct continued by Kirby Griffis, cross by David Dickens<\/p>\n

Day 17 B: 8\/3\/18<\/a>\u00a0\u2013 Dr. Timothy Kuzel, cross continued by David Dickens<\/p>\n

Day 18 A: 8\/7\/18<\/a>\u00a0\u2013 Plaintiff closing statement by Brent Wisner<\/p>\n

Day 18 B: 8\/7\/18<\/a>\u00a0\u2013 Defense closing statement by George Lombardi; Plaintiff final statement by Brent Wisner<\/p>\n

Plaintiff Closing Slide Presentation by R. Brent Wisner<\/a><\/p>\n

Day 19: 8\/8\/18<\/a>\u00a0\u2013 Jury intructions given; Jury asks for testimony of Dr. Nabhan<\/p>\n

Day 20: 8\/9\/18<\/a>\u00a0\u2013 Jury requests reading of stipulations, Monsanto\u2019s admissions, and Dr. Foster\u2019s testimony<\/p>\n

Dewayne Johnson v. Monsanto Trial Exhibits<\/strong><\/p>\n

PTX = Plaintiff Exhibits | DX = Defense Exhibits<\/em><\/p>\n

Day 1: 7\/9\/18<\/strong><\/p>\n

Plaintiff Opening Slide Presentation by R. Brent Wisner<\/a><\/p>\n

Defendant Opening Slide Presentation by George C. Lombardi<\/a><\/p>\n

Dr. Kirk Azevedo partial deposition transcript<\/a>, former Monsanto Sales Representative<\/p>\n

PTX 0004 \u2013 Photo of Dewayne Johnson in protective spray gear<\/a><\/p>\n

PTX 0006 \u2013 Photo of Dewayne Johnson in protective mask and suit<\/a><\/p>\n

PTX 0007 \u2013 Photo of Dewayne Johnson\u2019s family<\/a><\/p>\n

PTX 0009 \u2013 Photo of Dewayne Johnson and family<\/a><\/p>\n

PTX 0016 \u2013 Photo of tank and equipment<\/a><\/p>\n

PTX 0018 \u2013 Photo of Dewayne Johnson\u2019s hand<\/a><\/p>\n

PTX 0020 \u2013 Photo of Dewayne Johnson\u2019s lesions<\/a><\/p>\n

PTX 0021 \u2013 Photo of Dewayne Johnson\u2019s back<\/a><\/p>\n

PTX 0022 \u2013 Photo of Dewayne Johnson\u2019s torso<\/a><\/p>\n

PTX 0139 \u2013 John Acquavella and Donna Farmer review of Hardell & Eriksson<\/a><\/p>\n

PTX 0144 \u2013 Monsanto email from John Acquavella re: Epidemiology Studies on Glyphosate (2000)<\/a><\/p>\n

PTX 0182 \u2013 Photo of the IARC Working Group, Monograph 112<\/a><\/p>\n

PTX 0215 \u2013 Monsanto email re: Actions from 12\/17\/98 Meeting on Mutagenicity (1998)<\/a><\/p>\n

PTX 0216 \u2013 Monsanto email re: Draft of Minutes 1\/15\/99 Meeting (1999)<\/a><\/p>\n

PTX 0220 \u2013 Dr. James Parry: Evaluation of the Potential Genotoxicity of Glyphosate, Glyphosate Mixtures and Component Surfactants<\/a><\/p>\n

PTX 0221 \u2013 Monsanto email re: Parry Report<\/a><\/p>\n

PTX 0263 \u2013 Monsanto email re: Draft of Minutes 1\/15\/99 Meeting (1999)<\/a><\/p>\n

PTX 0264 \u2013 Dr. Parry report with handwritten comments (1999)<\/a><\/p>\n

PTX 0292 \u2013 Monsanto\u2019s IARC Strategy (Feb 2015)<\/a><\/p>\n

PTX 0293 \u2013 Differences in Carcinogenic Evaluation of Glyphosate Between IARC and EFSA (Portier, 2016)<\/a><\/p>\n

PTX 0294 \u2013 Monsanto email re: IARC Evaluation of Glyphosate (2014)<\/a><\/p>\n

PTX 0306 \u2013 American Cancer Society: Known and Probable Human Carcinogens<\/a><\/p>\n

PTX 0312 \u2013 Monsanto email re: McDuffee Article<\/a><\/p>\n

PTX 0366 \u2013 Monsanto email re: Document List (2015)<\/a><\/p>\n

PTX 0373 \u2013 Monsanto email re: Glyphosate Toxicology Activities (2010)<\/a><\/p>\n

PTX 0377 \u2013 Williams, Kroes, Munro Study<\/a><\/p>\n

PTX-0482-Monsanto email re: Glyphosate and NHL \/ Alachlor (2003)<\/a><\/p>\n

PTX 0513 \u2013 Monsanto email re: Beyond-Pesticides Article (2008)<\/a><\/p>\n

PTX 0669 \u2013 Glyphosate Use and Cancer Incidence in the AHS (2017)<\/a><\/p>\n

PTX 0686 \u2013 Genotoxic Activity of Glyphosate \/ Roundup Study (1997)<\/a><\/p>\n

PTX 0701 \u2013 Systematic Review and Meta-Analysis of Glyphosate Exposure and Risk of Lymphohematopoietic Cancers (2016)<\/a><\/p>\n

PTX 0710 \u2013 Integrative Assessment of Multiple Pesticides as Risk Factors for Non-Hodgkin\u2019s Lymphoma Among Men, De Roos (2003)<\/a><\/p>\n

PTX 0756 \u2013 Monsanto email re: Popular Herbicide Linked to Cancers<\/a><\/p>\n

PTX 0766 \u2013 Does Exposure to Glyphosate Lead to an Increase in the Micronuclei Frequency? A Systematic and Meta-Analytic Review (2016)<\/a><\/p>\n

PTX 0777 \u2013 Exposure to Pesticides as Risk Factor for Non-Hodgkin Lymphoma and Hairy Cell Leukemia: Pooled Analysis of Two Swedish Case-Control Studies<\/a><\/p>\n

PTX 0784 \u2013 IARC Glyphosate Monograph 112<\/a><\/p>\n

PTX 0809 \u2013 Genotoxicity and Oxidative Stress Induced by Pesticide Exposure in Bovine Lymphocyte Cultures in vitro (1998)<\/a><\/p>\n

PTX 0818 \u2013 Non-Hodgkin Lymphoma and Specific Pesticide Exposures in Men: Cross-Canada Study of Pesticides and Health (2001)<\/a><\/p>\n

PTX 0842 \u2013 P- Post Labeling Detection of DNA Adducts in Mice Treated with the Herbicide Roundup (1998)<\/a><\/p>\n

PTX 0852 \u2013 Genotoxicity testing of the herbicide Roundup and its active ingredient glyphosate isopropylamine using the mouse bone marrow micronucleus test, Salmonella mutagenicity test, and Allium anaphase-telophase test (1993)<\/a><\/p>\n

PTX 0861 \u2013 Non-Hodgkin Lymphoma and Occupational Exposure to Agricultural Pesticide Chemical Groups and Active Ingredients: A Systematic Review and Meta-Analysis (2014)<\/a><\/p>\n

Day 2: 7\/10\/18<\/strong><\/p>\n

Martens Depo Exhibits<\/strong><\/p>\n

Dr. Mark Martens partial deposition transcript<\/a>, former Monsanto Executive, Toxicology Agriculture Research & Development Director for Monsanto Europe<\/p>\n

DX 2181 \u2013 CV for Dr. Mark Martens<\/a><\/p>\n

PTX 0208 \u2013 Monsanto email re: Fellow Nomination (2001)<\/a><\/p>\n

PTX 0209 \u2013 Surfactant Toxicology Report: Europe and Africa<\/a><\/p>\n

PTX 0215 \u2013 Monsanto email re: Actions from 12\/17\/98 Meeting on Mutagenicity (1998)<\/a><\/p>\n

PTX 0216 \u2013 Monsanto email re: Draft of Minutes 1\/15\/99 Meeting (1999)<\/a><\/p>\n

PTX 0217 \u2013 CV for Dr. James Parry<\/a><\/p>\n

PTX 0218 \u2013 Monsanto email re: Meeting Minutes 2\/25 (1999)<\/a><\/p>\n

PTX 0219 \u2013 Monsanto email re: Comments on Parry write-up (1999)<\/a><\/p>\n

PTX 0220 \u2013 Dr. James Parry: Evaluation of the Potential Genotoxicity of Glyphosate, Glyphosate Mixtures and Component Surfactants<\/a><\/p>\n

PTX 0221 \u2013 Monsanto Email re: Parry Report<\/a><\/p>\n

PTX 0269 \u2013 Monsanto Email fw: Meeting Prof Parry 15 Feb 2001<\/a><\/p>\n

PTX 0270 \u2013 Monsanto Email re: Comments on Parry write-up (1999)<\/a><\/p>\n

Heydens Depo Exhibits<\/strong><\/p>\n

Dr. William Heydens partial deposition transcript<\/a>, Monsanto Company Product Safety Assessment Strategy Lead<\/p>\n

PTX 0294 \u2013 Monsanto email re: IARC Evaluation of Glyphosate (2014)<\/a><\/p>\n

PTX 0336 \u2013 Monsanto email re: Post-IARC Activities to Support Glyphosate (2015)<\/a><\/p>\n

PTX 0357 \u2013 Monsanto email re: CE Collaboration Project (2015)<\/a><\/p>\n

PTX 0359 \u2013 Monsanto email re: Need for telephone conversation\/Followup (2016)<\/a><\/p>\n

PTX 0361 \u2013 Consulting Agreement for Larry Kier (2015)<\/a><\/p>\n

PTX 0362 \u2013 Monsanto email re: IARC Planning (2015)<\/a><\/p>\n

PTX 0363 \u2013 Monsanto email re: Glyphosate Expert Panel Manuscripts (2016)<\/a><\/p>\n

PTX 0366 \u2013 Monsanto email re: Document List (2015)<\/a><\/p>\n

PTX 0368 \u2013 Monsanto email re: RE: summary article<\/a><\/p>\n

PTX 0369 \u2013 Monsanto email fw: Genotoxicity Panel Final Manuscript (2016)<\/a><\/p>\n

PTX 0373 \u2013 Monsanto Email re: Glyphosate Toxicology Activities (2010)<\/a><\/p>\n

PTX 0378 \u2013 Monsanto email re: Scientific Outreach Council Meeting (1999)<\/a><\/p>\n

PTX 0379 \u2013 Monsanto email re: Revised IARC reactive messaging (2015)<\/a><\/p>\n

PTX 0383 \u2013 Monsanto email re: KP Conversation on POEA (2010)<\/a><\/p>\n

PTX 0391 \u2013 Monsanto email re: Proposal for Post\u2010IARC Meeting Scientific Projects (2015)<\/a><\/p>\n

PTX 0394 \u2013 Monsanto email re: Declaration of Interest (2016)<\/a><\/p>\n

PTX 0883 \u2013 Critical Reviews in Toxicology: A review of the carcinogenic potential of glyphosate by four independent expert panels and comparison to the IARC assessment (2016)<\/a><\/p>\n

Day 3: 7\/12\/18\u00a0<\/strong><\/p>\n

PTX 0166 \u2013 IARC Preamble<\/a><\/p>\n

PTX 0292 \u2013 Monsanto\u2019s IARC Strategy (Feb 2015)<\/a><\/p>\n

PTX 0295 \u2013 IARC Monograph 112 list of participants<\/a><\/p>\n

PTX 0640 \u2013 EPA Guidelines for Carcinogen Risk Assessment (2005)<\/a><\/p>\n

PTX 0710 \u2013 Integrative assessment of multiple pesticides as risk factors for non-Hodgkin\u2019s lymphoma among men; De Roos (2003)<\/a><\/p>\n

PTX 0784 \u2013 IARC Glyphosate Monograph 112<\/a><\/p>\n

PTX 0818 \u2013 Non-Hodgkin Lymphoma and Specific Pesticide Exposures in Men: Cross-Canada Study of Pesticides and Health (2001)<\/a><\/p>\n

PTX 0884 \u2013 Safety Evaluation and Risk Assessment of the Herbicide Roundup and Its Active Ingredient, Glyphosate, for Humans; Williams, Kroes, Munro (2000)<\/a><\/p>\n

PTX 1020 \u2013 Demo 2: Mice Studies | Tumors Chart<\/a><\/p>\n

PTX 1021 \u2013 Demo 3: Rat Studies | Tumors Chart<\/a><\/p>\n

PTX 1022 \u2013 Demo 4: Epidemiology Plot Summary of ever\/never<\/a><\/p>\n

PTX 1023 \u2013 Demo 5: Confidence Interval Probability Curve<\/a><\/p>\n

PTX 1024 \u2013 Demo 6: Tumor Formation Diagram<\/a><\/p>\n

Day 4: 7\/13\/18<\/strong><\/p>\n

PTX 1030 \u2013 Estimated Agricultural Use of Glyphosate 1993 and 2015<\/a><\/p>\n

DX 2212 \u2013 Dr. Christopher Portier deposition transcript<\/a>, former Director of the Agency for Toxic Substances and Disease Registry, former Associate Director of the National Toxicology Program (NTP), former Associate Director of National Institutes of Health, former Director of the National Center for Environmental Health (NCEH) at the Centers for Disease Control and Prevention (CDC), former Director of the Agency for Toxic Substances and Disease Registry (ATSDR)<\/p>\n

DX 2320 \u2013 ECHA Committee for Risk Assessment Opinion proposing harmonised classification and labelling at EU level of glyphosate (2018)<\/a><\/p>\n

DX 2323 \u2013 EFSA: Conclusion on the peer review of the pesticide risk assessment of the active substance glyphosate (2015)<\/a><\/p>\n

DX 2403 \u2013 Dr. Christopher Portier Email re: IARC Monograph on Glyphosate (2015)<\/a><\/p>\n

DX 2437 \u2013 EPA Cancer Assessment Review Committee Evaluation of the Carcinogenic Potential of Glyphosate (2015)<\/a><\/p>\n

DX 2570 \u2013 Critical Reviews in Toxicology: Evaluation of carcinogenic potential of the herbicide glyphosate, drawing on tumor incidence data from fourteen chronic\/carcinogenicity rodent studies (2015)<\/a><\/p>\n

DX 2735 \u2013 Dr. Christopher Portier and others \u2013 open letter: Review of the Carcinogenicity of Glyphosate by EFSA and BfR (2015)<\/a><\/p>\n

DX 2747 \u2013 EFSA Responds to Dr. Christopher Portier\u2019s open letter: Review of the Carcinogenicity of Glyphosate by EFSA and BfR (2016)<\/a><\/p>\n

DX 2931 \u2013 Is Glyphosate Carcinogenic? Debate between Dr. Christopher Portier and Dr. Jose Tarazona<\/a><\/p>\n

Day 5: 7\/16\/18<\/strong><\/p>\n

No Exhibits<\/p>\n

Day 6: 7\/17\/18<\/strong><\/p>\n

William Heydens Depo Exhibits<\/strong><\/p>\n

Dr. William Heydens partial deposition transcript (continued from Day 3)<\/a>, Monsanto Company Product Safety Assessment Strategy Lead<\/p>\n

PTX 0259 \u2013 Ghost Writing Initiated by Commercial Companies \u2013 The World Association of Medical Editors<\/a><\/p>\n

PTX 0295 \u2013 IARC Monograph 112 list of participants<\/a><\/p>\n

PTX 0388 \u2013 Monsanto Email re: EPA openly discussed IARC findings at a CLA meeting on Thursday (2015)<\/a><\/p>\n

PTX 0392 \u2013 Monsanto Email re: John, Glyphosate Expert Panel Poster at 2015 SRA Meeting<\/a><\/p>\n

DX 2114 \u2013 Genotoxicity Expert Panel review: weight of evidence evaluation of the genotoxicity of glyphosate, glyphosate-based formulations, and aminomethylphosphonic acid (2016)<\/a><\/p>\n

DX 2220 \u2013 Deposition of Dewayne Johnson December of 2016<\/a><\/p>\n

DX 3010 \u2013 Glyphosate in the general population and in applicators: a critical review of studies on exposures; Solomon (2016)<\/a><\/p>\n

DX 3109 \u2013 Glyphosate rodent carcinogenicity bioassay expert panel review (2016)<\/a><\/p>\n

DX 3110 \u2013 Safety Evaluation and Risk Assessment of the Herbicide Roundup and Its Active Ingredient, Glyphosate, for Humans<\/a><\/p>\n

Daniel Jenkins Depo Exhibits<\/strong><\/p>\n

Daniel Jenkins final deposition transcript<\/a>, Monsanto\u2019s former US Agency Manager for Regulatory Affairs<\/p>\n

PTX 0371 \u2013 Monsanto Email re: A Review of the Carcinogenic Potential of Glyphosate by Four Independent Expert Panels and Comparison to the IARC Assessment (2016)<\/a><\/p>\n

PTX 0399 \u2013 Monsanto Email Fwd: US Government Outreach \u2013 WHO IARC Clarification on Glyphosate (2015)<\/a><\/p>\n

PTX 0400 \u2013 Monsanto Email to Michael Goodis, Jess Rowland and others at EPA (2015)<\/a><\/p>\n

PTX 0402 \u2013 Monsanto Email re: GA Update on US Government Outreach \u2013 WHO IARC Clarification on Glyphosate (2015)<\/a><\/p>\n

PTX 0403 \u2013 Monsanto Email re: ATSDR from Jack Housenger EPA (2015)<\/a><\/p>\n

PTX 0404 \u2013 Monsanto Email re: Glyphosate IARC Question (2015)<\/a><\/p>\n

Daniel Goldstein Depo Exhibits<\/strong><\/p>\n

Dr. Daniel Goldstein partial deposition transcript<\/a>, Monsanto Co. Lead, Medical Sciences and Outreach and Distinguished Science Fellow<\/p>\n

PTX 0309 \u2013 Monsanto Email re: NHL abstract (2000)<\/a><\/p>\n

PTX 0311 \u2013 Monsanto Email re: ISSE Meeting \u2013 epidemiology studies glyphosate (2004)<\/a><\/p>\n

PTX 0312 \u2013 Monsanto email re: McDuffee Article<\/a><\/p>\n

PTX 0313 \u2013 Monsanto Email re: McDuffee paper (2001)<\/a><\/p>\n

PTX 0314 \u2013 Email Article re: NHL and Glyphosate, Alachlor (2003)<\/a><\/p>\n

PTX 0315 \u2013 Monsanto Email re: FYI Aerial spraying of herbicide \u2018damages DNA\u2019 \u2013 SciDev.Net (2007)<\/a><\/p>\n

PTX 0316 \u2013 Monsanto Email re: Agenda \/ Awareness File \u2013 IMT (2008)<\/a><\/p>\n

PTX 0318 \u2013 Daniel Goldstein LinkedIn profile<\/a><\/p>\n

PTX 0319 \u2013 Monsanto Email re: New Paper (2014)<\/a><\/p>\n

PTX 0327 \u2013 Monsanto Community Safety and Health (Monsanto website)<\/a><\/p>\n

PTX 0332 \u2013 Monsanto Email re: Ranger Pro Exposure, Dewayne Johnson\u2019s story (2014)<\/a><\/p>\n

PTX 0333 \u2013 Monsanto Email re: March 2015 FIFRA 6(a)(2) Reports (2015)<\/a><\/p>\n

PTX 0334 \u2013 Human Exposure \/ Adverse Events Incidents Involving Monsanto Lawn & Garden Products, March 2015<\/a><\/p>\n

PTX 0335 \u2013 Monsanto Email re: Round-Up information for posting on the net (2004)<\/a><\/p>\n

Day 7: 7\/18\/18<\/strong><\/p>\n

PTX 0284 \u2013 IARC Monographs: 40 Years of Evaluating Carcinogenic Hazards to Humans; Portier, et al. (2015)<\/a><\/p>\n

PTX 0669 \u2013 Glyphosate Use and Cancer Incidence in the AHS (2017)<\/a><\/p>\n

PTX 0682 \u2013 Methodological Issues Regarding Confounding and Exposure Misclassification in Epidemiological Studies of Occupational Exposures; Blair, et al. (2007)<\/a><\/p>\n

PTX 0684 \u2013 Impact of Pesticide Exposure Misclassification on Estimates of Relative Risks in the Agricultural Health Study; Blair, et al. (2011)<\/a><\/p>\n

PTX 1029 \u2013 Dr. Alfred Neugut Demo: Forest Plots of Relative Risk\u00a0<\/a><\/p>\n

PTX 1032 \u2013 Glyphosate Use by Year and Crop<\/a><\/p>\n

PTX 1033 \u2013 Bradford-Hill Criteria for Causality<\/a><\/p>\n

PTX 1034 \u2013 Other Pesticides Missed by AHS<\/a><\/p>\n

DX 2052 \u2013 Glyphosate Use and Cancer Incidence in the Agricultural Health Study (2017)<\/a><\/p>\n

DX 2598 \u2013 Using multiple imputation to assign pesticide use for non-responders in the follow-up questionnaire in the Agricultural Health Study; Heltshe, et al. (2012)<\/a><\/p>\n

DX 3153 \u2013 Postdiagnosis Changes in Cigarette Smoking and Survival Following Breast Cancer; Parada Jr., et al. (2017)<\/a><\/p>\n

Day 8: 7\/20\/18<\/strong><\/p>\n

PTX 0332 \u2013 Monsanto Email re: Ranger Pro Exposure, Dewayne Johnson\u2019s story (2014)<\/a><\/p>\n

PTX 0333 \u2013 Monsanto Email re: March 2015 FIFRA 6(a)(2) Reports (2015)<\/a><\/p>\n

PTX 0820 \u2013 Minimum Latency & Types or Categories of Cancer (2015)<\/a><\/p>\n

PTX 1031 \u2013 Lee Johnson: Risk Factors for Non-Hodgkin Lymphoma (demonstrative board that was filled out before the court)<\/a><\/p>\n

PTX 1036 \u2013 The 2016 revision of the World Health Organization classification of lymphoid neoplasms; Swerdlow, et al.<\/a><\/p>\n

PTX 1039 \u2013 Lee Johnson Timeline<\/a><\/p>\n

DX 2191 \u2013 Cancer Incidence among Glyphosate-Exposed Pesticide Applicators in the Agricultural Health Study; De Roos, et al. (2005)<\/a><\/p>\n

DX 2193 \u2013 Integrative assessment of multiple pesticides as risk factors for non-Hodgkin\u2019s lymphoma among men; De Roos, et al. (2003)<\/a><\/p>\n

DX 2505 \u2013 Pesticide exposure as risk factor for non-Hodgkin lymphoma histopathological subgroup analysis; Eriksson, Hardell, et al. (2008)<\/a><\/p>\n

DX 2779 \u2013 Non-Hodgkin\u2019s Lymphoma and Specific Pesticide Exposures in Men: Cross-Canada Study of Pesticides and Health; McDuffie, et al. (2001)<\/a><\/p>\n

Day 9: 7\/23\/18<\/strong><\/p>\n

PTX 0006 \u2013 Photo of Dewayne Johnson in protective mask and suit<\/a><\/p>\n

PTX 0007 \u2013 Photo of Dewayne Johnson\u2019s family<\/a><\/p>\n

PTX 0012 \u2013 Photo of the Johnson Family Snowboarding<\/a><\/p>\n

PTX 0014b \u2013 Video of Dewayne Johnson talking about work<\/a><\/p>\n

PTX 0016 \u2013 Photo of tank and equipment<\/a><\/p>\n

PTX 0018 \u2013 Photo of Dewayne Johnson\u2019s hand<\/a><\/p>\n

PTX 0024 \u2013 Photo of Dewayne Johnson and his two sons<\/a><\/p>\n

PTX 32A \u2013 Photos of Dewayne Johnson, Oct. 3, 2014<\/a><\/p>\n

PTX 32B \u2013 Photos of Dewayne Johnson, Oct. 29, 2014<\/a><\/p>\n

PTX 32E \u2013 Photos of Dewayne Johnson, March and April, 2015<\/a><\/p>\n

PTX 32J \u2013 Photos of Dewayne Johnson, Sept. 3, 2015<\/a><\/p>\n

PTX 0045D \u2013 Photos of Dewayne Johnson, June, 2017<\/a><\/p>\n

PTX 0045E \u2013 Photos of Dewayne Johnson, Nov., 2017<\/a><\/p>\n

PTX 0045F \u2013 Photos of Dewayne Johnson, Jan., 2018<\/a><\/p>\n

PTX 0069 \u2013 Human Resources records for Dewayne Johnson, Benicia Unified School District (2017)<\/a><\/p>\n

PTX 0126 \u2013 Photo of Sprayer<\/a><\/p>\n

PTX 0332 \u2013 Monsanto Email re: Ranger Pro Exposure, Dewayne Johnson\u2019s story (2014)<\/a><\/p>\n

PTX 0334 \u2013 Human Exposure \/ Adverse Events Incidents Involving Monsanto Lawn & Garden Products, March 2015<\/a><\/p>\n

PTX 0848 \u2013 Ranger Pro Herbicide: Complete Directions for Use<\/a><\/p>\n

Day 10: 7\/24\/18<\/strong><\/p>\n

Partial Deposition of Donna Farmer<\/a><\/p>\n

Partial Deposition of Daniel Goldstein<\/a><\/p>\n

PTX 0227 \u2013 Monsanto email re: URGENT \u2013 Glyphosate IARC response-request for additional experts (2015)<\/a><\/p>\n

PTX 0258 \u2013 Monsanto email re: First Half\u2026 \u201cI added a section in genotox from the Gasnier study\u2026\u201d (2010)<\/a><\/p>\n

PTX 0261 \u2013 Monsanto email re: John, Glyphosate Expert Panel Poster at 2015 SRA Annual Meeting (2015)<\/a><\/p>\n

PTX 0263 \u2013 Monsanto email re: Draft of Minutes 1\/15\/99 Meeting (1999)<\/a><\/p>\n

PTX 0264 \u2013 Dr. Parry report with handwritten comments (1999)<\/a><\/p>\n

PTX 0265 \u2013 Etheramine Working Group Meeting Notes (1999)<\/a><\/p>\n

PTX 0266 \u2013 Monsanto email re: Mutagenicity assessment of Roundup by Parry (1999)<\/a><\/p>\n

PTX 0267 \u2013 Monsanto email re: micro-MN results (2000)<\/a><\/p>\n

PTX 0268 \u2013 Monsanto email re: Parry report (1999)<\/a><\/p>\n

PTX 0270 \u2013 Monsanto Email re: Comments on Parry write-up (1999)<\/a><\/p>\n

PTX 0271 \u2013 Donna Farmer Product Safety Center Toxicology Goals (2004)<\/a><\/p>\n

PTX 0272 \u2013 Dr. James Parry: Evaluation of the Potential Genotoxicity of Glyphosate, Glyphosate Mixtures and Component Surfactants (1999)<\/a><\/p>\n

PTX 0282 \u2013 Glyphosate Stewardship, Epidemiology and the Farm Family Exposure Study (2002)<\/a><\/p>\n

PTX 0292 \u2013 Monsanto\u2019s IARC Strategy (Feb 2015)<\/a><\/p>\n

PTX 0294 \u2013 Monsanto email re: IARC Evaluation of Glyphosate (2014)<\/a><\/p>\n

PTX 0304 \u2013 Monsanto IARC Media Training (2015)<\/a><\/p>\n

PTX 0305 \u2013 Monsanto email re: Roundup article in Fremantle Herald (2009)<\/a><\/p>\n

PTX 0336 \u2013 Monsanto email re: Post-IARC Activities to Support Glyphosate (2015)<\/a><\/p>\n

PTX 0357 \u2013 Monsanto email re: CE Collaboration Project (2015)<\/a><\/p>\n

PTX 0361 \u2013 Consulting Agreement for Larry Kier (2015)<\/a><\/p>\n

PTX 0363 \u2013 Monsanto email re: Glyphosate Expert Panel Manuscripts (2016)<\/a><\/p>\n

PTX 0366 \u2013 Monsanto email re: Document List (2015)<\/a><\/p>\n

PTX 0368 \u2013 Monsanto email re: RE: summary article<\/a><\/p>\n

PTX 0369 \u2013 Monsanto email fw: Genotoxicity Panel Final Manuscript (2016)<\/a><\/p>\n

PTX 0371 \u2013 Monsanto Email re: A Review of the Carcinogenic Potential of Glyphosate by Four Independent Expert Panels and Comparison to the IARC Assessment (2016)<\/a><\/p>\n

PTX 0373 \u2013 Monsanto email re: Glyphosate Toxicology Activities (2010)<\/a><\/p>\n

PTX 0378 \u2013 Monsanto email re: Scientific Outreach Council Meeting (1999)<\/a><\/p>\n

PTX 0379 \u2013 Monsanto email re: Revised IARC reactive messaging (2015)<\/a><\/p>\n

PTX 0388 \u2013 Monsanto Email re: EPA openly discussed IARC findings at a CLA meeting on Thursday (2015)<\/a><\/p>\n

PTX 0391 \u2013 Monsanto email re: Proposal for Post\u2010IARC Meeting Scientific Projects (2015)<\/a><\/p>\n

PTX 0392 \u2013 Monsanto Email re: John, Glyphosate Expert Panel Poster at 2015 SRA Meeting<\/a><\/p>\n

PTX 0400 \u2013 Monsanto Email to Michael Goodis, Jess Rowland and others at EPA (2015)<\/a><\/p>\n

PTX 0402 \u2013 Monsanto Email re: GA Update on US Government Outreach \u2013 WHO IARC Clarification on Glyphosate (2015)<\/a><\/p>\n

PTX 0404 \u2013 Monsanto Email re: Glyphosate IARC Question (2015)<\/a><\/p>\n

PTX 0513 \u2013 Monsanto email re: Beyond-Pesticides Article (2008)<\/a><\/p>\n

PTX 0556 \u2013 Monsanto Email re: NTP will be Evaluating Glyphosate now! (2016)<\/a><\/p>\n

DX 2513 \u2013 The Toxicity Profiles of Five Surfactants Used in Roundup Branded Agricultural Herbicides (2008)<\/a><\/p>\n

Day 11: 7\/25\/18<\/strong><\/p>\n

PTX 0309 \u2013 Monsanto Email re: NHL abstract (2000)<\/a><\/p>\n

PTX 0311 \u2013 Monsanto Email re: ISSE Meeting \u2013 epidemiology studies glyphosate (2004)<\/a><\/p>\n

PTX 0312 \u2013 Monsanto email re: McDuffee Article<\/a><\/p>\n

PTX 0313 \u2013 Monsanto Email re: McDuffee paper (2001)<\/a><\/p>\n

PTX 0314 \u2013 Email Article re: NHL and Glyphosate, Alachlor (2003)<\/a><\/p>\n

PTX 0315 \u2013 Monsanto Email re: FYI Aerial spraying of herbicide \u2018damages DNA\u2019 \u2013 SciDev.Net (2007)<\/a><\/p>\n

PTX 0316 \u2013 Monsanto Email re: Agenda \/ Awareness File \u2013 IMT (2008)<\/a><\/p>\n

PTX 0319 \u2013 Monsanto Email re: New Paper (2014)<\/a><\/p>\n

PTX 0321 \u2013 Monsanto Email re: ACSH (2015)<\/a><\/p>\n

PTX 0326 \u2013 Monsanto Email re: Adverse Event Reporting (2015)<\/a><\/p>\n

Day 12: 7\/26\/18<\/strong><\/p>\n

No Exhibits Admitted<\/p>\n

Day 13: 7\/27\/18<\/strong><\/p>\n

PTX 0154 \u2013 John Acquavella Discussion of Agricultural Health Study Limitations (1997)<\/a><\/p>\n

PTX 0166 \u2013 IARC Preamble<\/a><\/p>\n

PTX 0169 \u2013 IARC Glyphosate Monograph (2015)<\/a><\/p>\n

PTX 0258 \u2013 Monsanto email re: First Half\u2026 \u201cI added a section in genotox from the Gasnier study\u2026\u201d (2010)<\/a><\/p>\n

PTX 0261 \u2013 Monsanto email re: John, Glyphosate Expert Panel Poster at 2015 SRA Annual Meeting (2015)<\/a><\/p>\n

PTX 0263 \u2013 Monsanto email re: Draft of Minutes 1\/15\/99 Meeting (1999)<\/a><\/p>\n

PTX 0266 \u2013 Monsanto email re: Mutagenicity assessment of Roundup by Parry (1999)<\/a><\/p>\n

PTX 0267 \u2013 Monsanto email re: micro-MN results (2000)<\/a><\/p>\n

PTX 0271 \u2013 Donna Farmer Product Safety Center Toxicology Goals (2004)<\/a><\/p>\n

PTX 0288 \u2013 Monsanto Email re: Glyphosate Overview (2015)<\/a><\/p>\n

PTX 0289 \u2013 Monsanto Email re: CA and Glyphosate (2015)<\/a><\/p>\n

PTX 0290 \u2013 Monsanto Email re: \u201coverrun by liberals and morons\u2026sort of like a zombie movie\u201d (2015)<\/a><\/p>\n

PTX 0291 \u2013 Steven Gould: Cost on CA Municipalities Markets<\/a><\/p>\n

PTX 0299 \u2013 Monsanto Email re: Tools to help you address local concerns about IARC and litigation claims with glyphosate (2015)<\/a><\/p>\n

PTX 0304 \u2013 Monsanto IARC Media Training (2015)<\/a><\/p>\n

PTX 0305 \u2013 Monsanto email re: Roundup article in Fremantle Herald (2009)<\/a><\/p>\n

PTX 0443 \u2013 Monsanto Manuscript Clearance Form: Global Regulatory (2012)<\/a><\/p>\n

PTX 0445 \u2013 Monsanto Email re: Genotox Review; your approval requested! (2012)<\/a><\/p>\n

PTX 0537 \u2013 EPA Mouse Oncogenicity Study (1985)<\/a><\/p>\n

PTX 0591 \u2013 EPA Consensus Review of Glyphosate (1985)<\/a><\/p>\n

PTX 1020 \u2013 Demo 2: Mice Studies | Tumors Chart<\/a><\/p>\n

PTX 1021 \u2013 Demo 3: Rat Studies | Tumors Chart<\/a><\/p>\n

PTX 1035 \u2013 Dr. Neugut PowerPoint Presentation<\/a><\/p>\n

PTX 1043 \u2013 Glyphosate\u2019s Rise to the Top \u2014 EPA Rankings of the Top Pesticides by Year in the U.S. Agricultural Sector, 1987-2001<\/a><\/p>\n

PTX 0513 \u2013 Monsanto email re: Beyond-Pesticides Article (2008)<\/a><\/p>\n

PTX 0556 \u2013 Monsanto Email re: NTP will be Evaluating Glyphosate now! (2016)<\/a><\/p>\n

Day 14: 7\/30\/18<\/strong><\/p>\n

Dr. Aaron Blair Exhibits<\/strong><\/p>\n

PTX 0165 \u2013 CV for Dr. Aaron Blair<\/a><\/p>\n

PTX 0166 \u2013 IARC Preamble<\/a><\/p>\n

PTX 0167 \u2013 IARC Monographs on the Evaluation of Carcinogenic Risks to Humans VOLUME 112: List of Participants<\/a><\/p>\n

PTX 0168 \u2013 An Evaluation Of Glyphosate Use And The Risks Of Non-Hodgkin Lymphoma Major Histological Sub-Types In The North American Pooled Project (2015)<\/a><\/p>\n

PTX 0169 \u2013 IARC Glyphosate Monograph (2015)<\/a><\/p>\n

PTX 0173 \u2013 IARC Monographs: 40 Years of Evaluating Carcinogenic Hazards to Humans (2015)<\/a><\/p>\n

PTX 0664 \u2013 Increased Cancer Burden Among Pesticide Applicators and Others Due to Pesticide Exposure (2013)<\/a><\/p>\n

DX 2035 \u2013 DRAFT Lymphoma risk and pesticide use in the Agricultural Health Study (2013)<\/a><\/p>\n

DX 2036 \u2013 DRAFT Risk of total and cell specific non-Hodgkin Lymphoma and pesticide use in the Agricultural Health Study (2013)<\/a><\/p>\n

DX 2333 \u2013 Blair Email Chain (2014)<\/a><\/p>\n

DX 2336 \u2013 Blair Email Chain (2015)<\/a><\/p>\n

DX 2337 \u2013 Blair Email Chain (2015)<\/a><\/p>\n

DX 2339 \u2013 Blair Email Chain (2015)<\/a><\/p>\n

DX 2360 \u2013 Blair Email Chain (2015)<\/a><\/p>\n

DX 2374 \u2013 Blair Email Chain (2015)<\/a><\/p>\n

DX 2375 \u2013 Blair Email Chain (2014)<\/a><\/p>\n

DX 2379 \u2013 Blair Email Chain (2014)<\/a><\/p>\n

DX 2419 \u2013 Blair Email Chain (2016)<\/a><\/p>\n

DX 2424 \u2013 Blair Email Chain (2016)<\/a><\/p>\n

DX 2851 \u2013 2015 PowerPoint Presentation: Occupational Cancer Research Center<\/a>\u00a0\u2013 An Evaluation of Glyphosate Use and the Risk of Non-Hodgkin Lymphoma Major Histological Sub-Types in the North American Pooled Project<\/p>\n

Dr. Matthew Ross Exhibits<\/strong><\/p>\n

PTX 0293 \u2013 Differences in Carcinogenic Evaluation of Glyphosate Between IARC and EFSA (Portier, 2016)<\/a><\/p>\n

DX 2412 \u2013 Ross Email Chain (2015)<\/a><\/p>\n

DX 2413 \u2013 Ross Email Chain (2015)<\/a><\/p>\n

DX 2416 \u2013 Ross Email Chain (2015)<\/a><\/p>\n

DX 2580 \u2013 3\/6\/2015: Plenary General Remarks<\/a><\/p>\n

DX 2635 \u2013 IARC Preamble<\/a><\/p>\n

Day 15: 7\/31\/18<\/strong><\/p>\n

PTX 0293 \u2013 Differences in Carcinogenic Evaluation of Glyphosate Between IARC and EFSA (Portier, 2016)<\/a><\/p>\n

PTX 0681 \u2013 Patterns of Pesticide Use among Farmers: Implications for Epidemiologic Research; Blair & Zahm (1993)<\/a><\/p>\n

PTX 0682 \u2013 Methodological Issues Regarding Confounding and Exposure Misclassification in Epidemiological Studies of Occupational Exposures; Blair, et al. (2007)<\/a><\/p>\n

PTX 0709 \u2013 Cancer Incidence among Glyphosate-Exposed Pesticide Applicators in the Agricultural Health Study; De Roos et al. (2005)<\/a><\/p>\n

PTX 0710 \u2013 Integrative Assessment of Multiple Pesticides as Risk Factors for Non-Hodgkin\u2019s Lymphoma Among Men, De Roos (2003)<\/a><\/p>\n

PTX 0777 \u2013 Exposure to Pesticides as Risk Factor for Non-Hodgkin Lymphoma and Hairy Cell Leukemia: Pooled Analysis of Two Swedish Case-Control Studies<\/a><\/p>\n

PTX 0778 \u2013 A Case-Control Study of Non-Hodgkin Lymphoma and Exposure to Pesticides; Hardell, Eriksson (1999)<\/a><\/p>\n

PTX 0818 \u2013 Non-Hodgkin Lymphoma and Specific Pesticide Exposures in Men: Cross-Canada Study of Pesticides and Health (2001)<\/a><\/p>\n

DX 2052 \u2013 Glyphosate Use and Cancer Incidence in the Agricultural Health Study (2017)<\/a><\/p>\n

DX 2191 \u2013 Cancer Incidence among Glyphosate-Exposed Pesticide Applicators in the Agricultural Health Study; De Roos, et al. (2005)<\/a><\/p>\n

DX 2193 \u2013 Integrative assessment of multiple pesticides as risk factors for non-Hodgkin\u2019s lymphoma among men; De Roos, et al. (2003)<\/a><\/p>\n

DX 2333 \u2013 Blair Email Chain (2014)<\/a><\/p>\n

DX 2336 \u2013 Blair Email Chain (2015)<\/a><\/p>\n

DX 2337 \u2013 Blair Email Chain (2015)<\/a><\/p>\n

DX 2339 \u2013 Blair Email Chain (2015)<\/a><\/p>\n

DX 2360 \u2013 Blair Email Chain (2015)<\/a><\/p>\n

DX 2374 \u2013 Blair Email Chain (2015)<\/a><\/p>\n

DX 2375 \u2013 Blair Email Chain (2014)<\/a><\/p>\n

DX 2412 \u2013 Ross Email Chain (2015)<\/a><\/p>\n

DX 2413 \u2013 Ross Email Chain (2015)<\/a><\/p>\n

DX 2416 \u2013 Ross Email Chain (2015)<\/a><\/p>\n

DX 2419 \u2013 Blair Email Chain (2016)<\/a><\/p>\n

DX 2424 \u2013 Blair Email Chain (2016)<\/a><\/p>\n

DX 2505 \u2013 Pesticide exposure as risk factor for non-Hodgkin lymphoma histopathological subgroup analysis; Eriksson, Hardell, et al. (2008)<\/a><\/p>\n

DX 2580 \u2013 3\/6\/2015: Plenary General Remarks<\/a><\/p>\n

DX 2584 \u2013 Exposure to Pesticides as Risk Factor for Non-Hodgkin\u2019s Lymphoma and Hairy Cell Leukemia: Pooled Analysis of Two Swedish Case-control Studies; Hardell, et al. (2002)<\/a><\/p>\n

DX 2598 \u2013 Using multiple imputation to assign pesticide use for non-responders in the follow-up questionnaire in the Agricultural Health Study; Heltshe, et al. (2012)<\/a><\/p>\n

DX 2779 \u2013 Non-Hodgkin\u2019s Lymphoma and Specific Pesticide Exposures in Men: Cross-Canada Study of Pesticides and Health; McDuffie, et al. (2001)<\/a><\/p>\n

DX 2867 \u2013 An Evaluation of Glyphosate Use and the Risk of Non-Hodgkin Lymphoma Major Histological Sub-Types in the North American Pooled Project, PowerPoint Presentation (2015)<\/a><\/p>\n

Day 16: 8\/2\/18<\/strong><\/p>\n

PTX 0762 \u2013 FIFRA Scientific Advisory Panel Meeting Minutes and Final Report: EPA\u2019s Evaluation of the Carcinogenic Potential of Glyphosate, 2017<\/a><\/p>\n

PTX 0765 \u2013 Studies on glyphosate-induced carcinogenicity in mouse skin: A proteomic approach; George, et. al (2009)<\/a><\/p>\n

PTX 1020 \u2013 Demo 2: Mice Studies | Tumors Chart<\/a><\/p>\n

PTX 1021 \u2013 Demo 3: Rat Studies | Tumors Chart<\/a><\/p>\n

PTX 1062 \u2013 OECD Guideline for the Testing of Chemicals: Carcinogenicity Studies (2018)<\/a><\/p>\n

PTX 1063 \u2013 Spontaneous Neoplastic Lesions in the CrI:CD-1(ICR) Mouse in Control Groups from 18 Month to 2 year Studies (2005)<\/a><\/p>\n

DX 2071 \u2013 CLH report Proposal for Harmonised Classification and Labelling: Glyphosate (2008)<\/a><\/p>\n

DX 2481 \u2013 Glyphosate Issue Paper: Evaluation of Carcinogenic Potential | EPA\u2019s Office of Pesticide Programs (2016)<\/a><\/p>\n

DX 2486 \u2013 Revised Glyphosate Issue Paper: Evaluation of Carcinogenic Potential EPA\u2019s Office of Pesticide Programs (2017)<\/a><\/p>\n

DX 2489 \u2013 EPA Reregistration Eligibility Decision: Glyphosate (1993)<\/a><\/p>\n

DX 2552 \u2013 Spontaneous Neoplastic Lesions in the CrI:CD-I (ICR)BR Mouse (2000)<\/a><\/p>\n

DX 2570 \u2013 Critical Reviews in Toxicology: Evaluation of carcinogenic potential of the herbicide glyphosate, drawing on tumor incidence data from fourteen chronic\/carcinogenicity rodent studies (2015)<\/a><\/p>\n

DX 2865 \u2013 OECD Guideline for the Testing of Chemicals: Combined Chronic Toxicity Carcinogenicity Studies (2009)<\/a><\/p>\n

DX 3114 \u2013 Summary Histopathology Data for 18 Month Control Study Safepharm Laboratories Internal Project 0041-0216 (2008)<\/a><\/p>\n

Dewayne Johnson v. Monsanto Court Documents<\/strong><\/p>\n

Order on Deposition Designations and Certain Proposed Jury Instructions<\/a>(23 pages) (5.17.18)\u00a0\u2013\u00a0<\/strong>Judge rules plaintiffs can present punitive damages in CA State Court case DEWAYNE JOHNSON vs. MONSANTO COMPANY, ET AL. Deposition designations start on page 17. Rulings are\u00a0in limine<\/em>\u00a0and so subject to review by trial judge as the trial progresses.<\/p>\n

Order on (1) Monsanto\u2019s Omnibus\u00a0Sargon\u00a0<\/em>Motion; (2) Monsanto\u2019s Motion for Summary Judgment; (3) Plaintiff\u2019s Omnibus\u00a0Sargon\u00a0<\/em>Motion; (4) Plaintiff\u2019s Motion for Summary Adjudication<\/a>\u00a0(48 pages) (5.17.18)\u00a0\u2013\u00a0<\/strong>Judge issues ruling in CA State Court case DEWAYNE JOHNSON vs. MONSANTO COMPANY, ET AL.
\nMonsanto\u2019s Omnibus\u00a0Sargon\u00a0<\/em>Motion: The judge ruled to exclude Dr. Portier\u2019s pooling analysis and any conclusions that depend on it, Dr. Sawyer\u2019s water permeability test and cancer slope opinions, certain testimony from Dr. Benbrook and Dr. Mills\u2019 opinion as to total lost income. Otherwise motion was denied.<\/p>\n

    \n
  1. Monsanto\u2019s Motion for Summary Judgment and Adjudication: The motions were denied.<\/li>\n<\/ol>\n
      \n
    1. Plaintiff\u2019s Omnibus\u00a0Sargon\u00a0<\/em>Motion: The judge ruled to exclude Dr. Rider\u2019s opinion that the epidemiological evidence precludes the conclusion that there is a causal relationship between glyphosate exposure and non-Hodgkin lymphoma, Dr. Kuzel\u2019s mycosis fungoides latency opinion, although Dr. Kuzel may opine generally as to latency for cancers. Otherwise the motion is denied.<\/li>\n<\/ol>\n
        \n
      1. Plaintiff\u2019s Motion for Summary Adjudication: The motion was granted.<\/li>\n<\/ol>\n

        Complaint\u00a0Dewayne Johnson v. Monsanto Co.\u00a0<\/em><\/a>(50 pages) (1.28.16)<\/p>\n

        Johnson vs Monsanto Trial News<\/strong><\/p>\n

        ABC News 7 San Francisco –\u00a0Opening arguments begin in lawsuit over Roundup weed killer<\/a><\/p>\n

        The Guardian \u2013\u00a0Monsanto \u2018bullied scientists\u2019 and hid weedkiller cancer risk, lawyer tells court<\/a><\/p>\n

        US Right to Know Carey Gillam Blog:\u00a0First Monsanto Roundup Cancer Trial Jury Selection<\/a><\/p>\n

        Courthouse News \u2013\u00a0Trial Begins Over Claim That Roundup Causes Cancer<\/a><\/p>\n

        KPIX CBS News TV \u2013\u00a0Trial Begins Seeking To Prove Monsanto\u2019s Roundup Caused Man\u2019s Cancer<\/a><\/p>\n

        Glyphosate Girl \u2013\u00a0Blog about the trial<\/a><\/p>\n